Home / Companies / Bakx Therapeutics Inc / Wages
Bakx Therapeutics Inc H-1B wage rows
Compensation-first LCA rows for Bakx Therapeutics Inc, including offered wage, annualized wage, worksite, SOC code, fiscal year, QA flags, and source record evidence. Showing 2 returned rows using keyset pagination.
Summary
This view lists 2 H-1B LCA wage observations.
Offered wages among the returned rows range from $140,000 to $140,000.
Employers in the returned rows include BAKX Therapeutics Inc..
LCA filings are labor-condition applications certified by the U.S. Department of Labor, not active job postings or approved USCIS H-1B petitions.
Returned-page wage summary
| Scope | returned_page |
| Count | 2 |
| Annualized Min | 140,000 |
| Annualized P25 | 140,000 |
| Annualized Median | 140,000 |
| Annualized P75 | 140,000 |
| Annualized P90 | 140,000 |
| Annualized Max | 140,000 |
| Outlier Count | 0 |
| Role | Employer | SOC | Fiscal year | Worksite | Annualized offer | Spread | QA flags | Source |
|---|---|---|---|---|---|---|---|---|
| Senior Scientist I-200-22098-050709 | BAKX Therapeutics Inc. | 19-1029.02 Molecular and Cellular Biologists | FY2023 Q4 | Watertown, MA, 02472 | $140,000 year | $26,786 | missing_offer_high | sr_dol_oflc_lca_2023_q4_row_118102 |
| Senior Scientist I-200-22098-050709 | BAKX Therapeutics Inc. | 19-1029.02 Molecular and Cellular Biologists | FY2022 Q3 | Watertown, MA, 2472 | $140,000 year | $26,786 | missing_offer_high | sr_dol_oflc_lca_2022_q3_row_033476 |
End of returned pageReset
Frequently asked questions
- What are the offered H-1B wages for Bakx Therapeutics Inc H-1B wage rows?
- Offered wages among the returned Bakx Therapeutics Inc H-1B wage rows rows range from $140,000 to $140,000 in DOL LCA filings. LCA filings are labor-condition applications certified by the U.S. Department of Labor, not active job postings or approved USCIS H-1B petitions.
Get this page with API
Rendered from the bluedoor H-1B Jobs API. Reproduce it:
GET https://api.bluedoor.sh/h1b-jobs/v1/wages?limit=50&company=bakx+therapeutics+incJSON